Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.21.2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Accumulated amortization of deferred leasing costs $ 31,975 $ 30,375
Common Shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common Shares of beneficial interest, shares authorized (in shares) 150,000,000 150,000,000
Common Shares of beneficial interest issued (in shares) 112,325,411 112,181,759
Common Shares of beneficial interest, shares outstanding (in shares) 112,325,411 112,181,759
Investing Receivables    
Investing receivable allowance for credit loss $ 1,415 $ 2,851